公司新闻
更多>>公司公告
更多>>- 10/19NUFORMIX PLC--NXP002 Development Update
- 08/25NUFORMIX PLC--Appointment of Chairman
- 08/19NUFORMIX PLC--NXP002 Development Update
- 10/28NUFORMIX PLC--Circular - UNDERWRITTEN OPEN OFFER OF 114,040,535 OPEN OFFER SHARES AT 0.2 PENCE PER OPEN OFFER SHARE
- 05/28NUFORMIX PLC--Half Year Report
- 03/31NUFORMIX PLC--Total Voting Rights
- 03/03NUFORMIX PLC--Result of AGM
- 03/10NUFORMIX PLC--Confirmation of US ODD for NXP002 in IPF
- 02/05NUFORMIX PLC--Posting of Annual Report and Notice of AGM
- 10/10Nuformix PLC--Change of Auditor
- 01/27NUFORMIX PLC--Annual Results for period ended 30 September 2025
- 09/25Nuformix PLC--European Respiratory Society Congress Attendance
- 11/28NUFORMIX PLC--Total Voting Rights
- 11/12NUFORMIX PLC--Update re. US FDA ODD Application